Follow
Lung-Yi Mak
Lung-Yi Mak
Verified email at hku.hk
Title
Cited by
Cited by
Year
hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection
LY Mak, DKH Wong, KS Cheung, WK Seto, CL Lai, MF Yuen
Alimentary pharmacology & therapeutics 47 (1), 43-54, 2018
2242018
Global epidemiology, prevention, and management of hepatocellular carcinoma
LY Mak, V Cruz-Ramón, P Chinchilla-López, HA Torres, NK LoConte, ...
American Society of Clinical Oncology Educational Book 38, 262-279, 2018
2162018
Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance
LY Mak, DKH Wong, T Pollicino, G Raimondo, FB Hollinger, MF Yuen
Journal of Hepatology 73 (4), 952-964, 2020
1392020
Inverse relationship between hepatic steatosis and hepatitis B viremia: results of a large case‐control study
RWH Hui, WK Seto, KS Cheung, LY Mak, KSH Liu, J Fung, DKH Wong, ...
Journal of viral hepatitis 25 (1), 97-104, 2018
1132018
Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis B
WK Seto, RWH Hui, LY Mak, J Fung, KS Cheung, KSH Liu, DKH Wong, ...
Clinical Gastroenterology and Hepatology 16 (4), 575-583. e2, 2018
1112018
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
LY Mak, RWH Hui, J Fung, F Liu, DKH Wong, KS Cheung, MF Yuen, ...
Journal of hepatology 73 (4), 800-806, 2020
1052020
Seven-year treatment outcome of entecavir in a real-world cohort: effects on clinical parameters, HBsAg and HBcrAg levels
YF Lam, WK Seto, D Wong, KS Cheung, J Fung, LY Mak, J Yuen, ...
Clinical and translational gastroenterology 8 (10), e125, 2017
1052017
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
WK Seto, KSH Liu, LY Mak, G Cloherty, DKH Wong, J Gersch, YF Lam, ...
Gut 70 (4), 775-783, 2021
822021
HBV RNA profiles in patients with chronic hepatitis B under different disease phases and antiviral therapy
LY Mak, G Cloherty, DKH Wong, J Gersch, WK Seto, J Fung, MF Yuen
Hepatology 73 (6), 2167-2179, 2021
692021
Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B
LY Mak, WK Seto, J Fung, MF Yuen
Hepatology International 14, 35-46, 2020
592020
Nidogen 1‐enriched extracellular vesicles facilitate extrahepatic metastasis of liver cancer by activating pulmonary fibroblasts to secrete tumor necrosis factor receptor 1
X Mao, SK Tey, CLS Yeung, EML Kwong, YME Fung, CYS Chung, ...
Advanced Science 7 (21), 2002157, 2020
582020
Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance
J Fung, KS Cheung, DKH Wong, LY Mak, WP To, WK Seto, CL Lai, ...
Hepatology 68 (2), 462-472, 2018
572018
Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD-a systematic review and meta-analysis
A Tang, CH Ng, PH Phang, KE Chan, YH Chin, CE Fu, RW Zeng, J Xiao, ...
Clinical Gastroenterology and Hepatology 21 (7), 1750-1760. e12, 2023
552023
Epidemiology and natural history of Wilson’s disease in the Chinese: a territory-based study in Hong Kong between 2000 and 2016
KS Cheung, WK Seto, J Fung, LY Mak, CL Lai, MF Yuen
World Journal of Gastroenterology 23 (43), 7716, 2017
542017
Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement”
LY Mak, MF Yuen, WK Seto
Journal of hepatology 73 (6), 1573-1574, 2020
492020
Hepatocellular carcinoma: recent advances and emerging medical therapies
KL Ko, LY Mak, KS Cheung, MF Yuen
F1000Research 9, 2020
492020
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
CH Ng, KE Chan, YH Chin, RW Zeng, PC Tsai, WH Lim, DJH Tan, ...
Clinical and Molecular Hepatology 28 (3), 565, 2022
462022
Novel developments of hepatitis B: treatment goals, agents and monitoring tools
LY Mak, WK Seto, J Fung, MF Yuen
Expert review of clinical pharmacology 12 (2), 109-120, 2019
462019
Fibrosis evolution in chronic hepatitis B e antigen‐negative patients across a 10‐year interval
LY Mak, WK Seto, RWH Hui, J Fung, DKH Wong, CL Lai, MF Yuen
Journal of viral hepatitis 26 (7), 818-827, 2019
452019
A territorywide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong
KSH Liu, WK Seto, EHY Lau, DKH Wong, YF Lam, KS Cheung, LY Mak, ...
The Journal of infectious diseases 219 (12), 1924-1933, 2019
432019
The system can't perform the operation now. Try again later.
Articles 1–20